LY393558, a 5-hydroxytryptamine reuptake inhibitor and 5-HT 1B/1D receptor antagonist: effects on extracellular levels of 5-hydroxytryptamine in the guinea pig and rat

By Mitchell S.N.   Greenslade R.G.   Cooper J.  

European Journal of Pharmacology, Vol. 432, Iss. 1, 2001-11 ,pp. : 19-27

Elsevier

Access to resources Recommend Favorite

Characterization of a new muscarinic receptor antagonist PNU-171990 in guinea pig, cat and human smooth muscle

By Modiri A.-R.   Vasange M.   Alberts P.   Jossan S.S.   Sundquist S.   Gillberg P.-G.  

European Journal of Pharmacology, Vol. 451, Iss. 2, 2002-09 ,pp. : 171-175

Elsevier

Access to resources Recommend Favorite

Antinociception in rat by sarpogrelate, a selective 5-HT 2A receptor antagonist, is peripheral

By Obata H.   Saito S.   Ishizaki K.   Goto F.  

European Journal of Pharmacology, Vol. 404, Iss. 1, 2000-09 ,pp. : 95-102

Elsevier

Access to resources Recommend Favorite

Enhancement of antipsychotic-like properties of the dopamine D 2 receptor antagonist, raclopride, by the additional treatment with the 5-HT 2 receptor blocking agent, ritanserin, in the rat

By Wadenberg M.-L.   Salmi P.   Jimenez P.   Svensson T.   Ahlenius S.  

European Neuropsychopharmacology, Vol. 6, Iss. 4, 1996-11 ,pp. : 305-310

Elsevier

Access to resources Recommend Favorite

Effect of a Novel 5-Hydroxytryptamine 3 (5-HT 3 ) Receptor Antagonist, GK-128, on 5-HT 3 Receptors Mediating Contractions and Relaxations in Guinea-Pig Distal Colon

By Ito C.   Kawamura R.   Isobe Y.   Tsuchida K.   Muramatsu M.   Higuchi S.  

General Pharmacology, Vol. 29, Iss. 3, 1997-09 ,pp. : 353-359

Elsevier

Access to resources Recommend Favorite